Women's cancer prevention and management
Women's cancer prevention and management is a research topic within Public Health, Environmental and Occupational Health. Science Explorer counts 11k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the prevention, diagnosis, treatment, and psychosocial impact of cervical cancer and breast cancer in women. It covers topics such as the Papanicolaou test, mastectomy experiences, healthcare access, social support, and the overall quality of life for women affected by these cancers.
- Cervical Cancer
- Papanicolaou Test
- Mastectomy
- Breast Cancer
- Women's Health
- Preventive Care
- Psychological Impact
- Healthcare Access
- Social Support
- Quality of Life
- Research works
- 11k fractional, since 1950
- In the world top 10%
- 1.1k per year above
- Top-10% rate
- 10.0% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +46% the tick is no change
- Largest producer
Brazil
80% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Women's cancer prevention and management research?
By volume, Brazil and the United States publish the most (2.8k and 215 works in 2022-now).
By volume, 2022-now
- 1
Brazil 2.8k works
- 2
United States 215 works
- 3
Portugal 81 works
- 4
Mexico 76 works
- 5
Spain 71 works
- 6
United Kingdom 60 works
- 7
China 57 works
- 8 ?? 45 works
- 9
Uruguay 42 works
- 10
India 40 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Women's cancer prevention and management research?
By volume in 2022-now, Instituto Nacional de Câncer - INCA publishes the most Women's cancer prevention and management research, followed by Universidade de São Paulo and Universidade Federal do Pará.
By volume, 2022-now
- 1
Instituto Nacional de Câncer - INCA
Brazil 109 works
- 2
Universidade de São Paulo
Brazil 56 works
- 3
Universidade Federal do Pará
Brazil 40 works
- 4
Universidade do Estado do Pará
Brazil 39 works
- 5
Universidade Federal Fluminense
Brazil 37 works
- 6
Universidade Federal do Ceará
Brazil 37 works
- 7
Fundação Oswaldo Cruz
Brazil 35 works
- 8
Universidade de Brasília
Brazil 33 works
- 9
Universidade Federal de Minas Gerais
Brazil 33 works
- 10
Universidade Federal de Pernambuco
Brazil 32 works
Who are the leading researchers in Women's cancer prevention and management?
The most-cited researchers publishing on Women's cancer prevention and management include Freddie Bray, Jacques Ferlay and Carlo La Vecchia.
- 1
Freddie Bray
France 550k citations
- 2
Jacques Ferlay
France 486k citations
- 3
Carlo La Vecchia
Italy 258k citations
- 4
Rafael Lozano
United States 224k citations
- 5
Elisabete Weiderpass
France 221k citations
- 6
Benn K. D. Sartorius
South Africa 208k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Women's cancer prevention and management research done?
The largest centres of Women's cancer prevention and management research in 2022-now are São Paulo (Brazil), Rio de Janeiro (Brazil), Recife (Brazil) and Belém (Brazil). Among places with at least 20 works in it, it is an unusually large share of all research in Vassouras and Maldonado.
Largest cities, 2022-now
Where it is the local speciality
- VassourasBR · 24.2 works115×
- MaldonadoUY · 23.6 works79×
Location quotient: how much more of its research is in Women's cancer prevention and management than the world average.
Where is the best place to study Women's cancer prevention and management?
Among universities, judged by research, Universidade de São Paulo, Universidade Federal de Minas Gerais and Universidade Federal do Espírito Santo score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Women's cancer prevention and management, country by countryIs Women's cancer prevention and management research growing?
Output in 2022-2025 was 46% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Women's cancer prevention and management.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Women's cancer prevention and management as a percentage of every work published that year, 0.017% in 2024.
Fractional works of Women's cancer prevention and management over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Women's cancer prevention and management. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.